October 02, 2024 09:43 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vestigo Ventures, an early-stage venture capital firm investing in transformative FinTech companies, proudly announced its participation in a $22 million Series B round in Roots…
According to filings with the U.S. Securities and Exchange Commission, Surgicure Technologies is raising up to $2,112,315.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Irena King played a…
September 04, 2024 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing….
Strong Valuation Underscores Significant Confidence in 24M Innovations and Accelerating Progress toward Mass Production and Commercialization September 05, 2024 12:45 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–24M today announced it has closed an $87 million…
According to filings with the U.S. Securities and Exchange Commission, SurgiBox is raising up to $1,000,000.00 in new funding. Sources indicate that as part of senior management Co-Founder, Mike Teodorescu played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Muon Vision is raising up to $2,500,553.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Tancredi Botto played a…
According to filings with the U.S. Securities and Exchange Commission, Convergent Therapeutics is raising up to $39,999,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Kantoff played a…
According to filings with the U.S. Securities and Exchange Commission, Artax Biopharma is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management President, Robert Armstrong played a key role…
According to filings with the U.S. Securities and Exchange Commission, Cognito Therapeutics is raising up to $60,032,626.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brent Vaughan played a…
June 26, 2024 04:00 AM Pacific Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–We’re excited to announce today that we have closed $380 million for our latest fund, bringing the total funds raised by Curie.Bio to nearly $1…